Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $1.95 Million - $2.28 Million
-35,528 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $1.65 Million - $2.4 Million
35,528 New
35,528 $1.98 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Atlas Principals, LLC Portfolio

Follow Atlas Principals, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Principals, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Principals, LLC with notifications on news.